Normal view MARC view ISBD view

The focal adhesion-associated proteins DOCK5 and GIT2 comprise a rheostat in control of epithelial invasion. [electronic resource]

By:

Frank, S R

Contributor(s):

Producer: 20170901Description: 1816-1828 p. digitalISSN:

1476-5594

Subject(s):

Online resources:

Available from publisher's website

In: Oncogene vol. 36

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1281 [Severe or life-threatening interactions between antiretrovirals and non-HIV drugs].
by Manzardo, Christian
1282 Fluoxetine- and norfluoxetine-mediated complex drug-drug interactions: in vitro to in vivo correlation of effects on CYP2D6, CYP2C19, and CYP3A4.
by Sager, J E
1283 Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine.
by Choi, Jin-Seok
1284 Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
by Mouly, Stéphane
1285 Population Pharmacokinetic Analysis of the Cathepsin K Inhibitor Odanacatib: Insights Into Intrinsic and Extrinsic Factor Effects on Exposure in Postmenopausal and Elderly Women.
by Jaworowicz, David
1286 Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail.
by Sevior, D K
1287 Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's Wort - and beyond!
by Nowack, Rainer
1288 Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations.
by Karonen, Tiina
1289 Potent and novel 11β-HSD1 inhibitors identified from shape and docking based virtual screening.
by Xia, Guangxin
1290 Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants.
by Malati, Christine Y
1291 Stereoselective metabolism of tetrahydropalmatine enantiomers in rat liver microsomes.
by Zhao, Ming
1292 Design, synthesis, and structure-activity relationship studies of novel thioether pleuromutilin derivatives as potent antibacterial agents.
by Ling, Chenyu
1293 Plasma concentrations of tyrosine kinase inhibitors imatinib, erlotinib, and sunitinib in routine clinical outpatient cancer care.
by Lankheet, Nienke A G
1294 [Biochemical and pharmacological features of telaprevir].
by Andrade, Raúl J
1295 A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies.
by de Jong, Jan
1296 Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.
by Fenneteau, Frederique
1297 In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
by Pan, Yan
1298 Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting.
by Eskazan, Ahmet Emre
1299 Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis.
by Thompson, Andrew M
1300 Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women.
by Tamraz, Bani